A double-blind, placebo-controlled trial of tiagabine given three-times daily as add-on therapy for refractory partial seizures. Northern European Tiagabine Study Group. - Kälviäinen,R.; Brodie,M.J.; Duncan,J. (Epilepsy Res, 1998)